Procyrion is dedicated to improving outcomes for patients with cardiac and renal impairment using its catheter-deployed pump technology to address conditions with significant unmet needs. Aortix™ is a percutaneous mechanical circulatory support device that treats cardiorenal syndrome with a rapidly-deployed intra-aortic catheter-based system.

Aortix™ is currently in the research and development phase and is not available for sale in any country.
(Caution: investigational device. Limited by federal law to investigational use.)

Scientific Health Development Partners

Aquinas

Jefferson River Capital

BlueBird Merchant Ventures

Fannin Innovation Studio

Houston Angel Network

Procyrion, Inc.

Our DRAIN-HF trial evaluating the #Aortix pump for acute decompensated #heartfailure patients is well underway. Congrats to Henry Ford Hospital and John Muir Hospital for enrolling multiple patients in this important study! 

#clinicaltrials #cardiorenalsyndrome #diureticresistance #innovation

Another DRAIN-HF site begins patient enrollment! Congrats to Dr. Miguel Alvarez Villela and the Northwell Health Lenox Hill team on enrolling your first patient in this groundbreaking trial for #heartfailure patients. 
 
#clinicaltrials #cardiorenalsyndrome #diureticresistance #Aortix #innovation

BREAKING NEWS: We are proud to be recognized as a #Fierce15 Medtech company this year! Check out the interview with our CEO Eric Fain to learn more about our innovative Aortix technology and the potential it has to change the way patients with acute decompensated #heartfailure and cardiorenal syndrome are treated.

https://lnkd.in/gR47YYhU

First DRAIN-HF enrollment in the Bay Area! Congrats to Dr. Andrew Dublin, Dr. Wayland Lim and the team at John Muir Health on enrolling your first patient in this groundbreaking trial of Aortix for #heartfailure patients.  
#clinicaltrials #cardiorenalsyndrome #diureticresistance

Our President & CEO Eric Fain had the opportunity to connect with Tom Salemi, host of the DeviceTalks podcast, earlier this week. Eric details how our recent $57.7 million round will help us in our quest to make the company's innovative Aortix technology available to physicians and patients with acute decompensated heart failure and cardiorenal syndrome. 
https://bit.ly/3SvX7HD

Amazon

DNSSEC

Google Apps for Business

Apple iCloud Mail

Amazon Ireland Region

Google Domains

Google DNS

Google Cloud DNS

Senior Vice President, Development and Manufacturing

Av Edidin

Vice President, Product Development

Chris Durst

Vice President of Quality

Katherine Cox

Controller

James Toll

Director, Field Clinical Engineering

Kevin McDonald

Director, Program Management

Omar Benavides

Director of Product Development

Ronnie Earles

Operations

Tamara Shipman

Associate Director

Tara Burt

Field Clinical Engineer

Aaron Palmer

Leo Linbeck III

Jeff Bird

Benjamin A. Hertzog

President & CEO

Jason Heuring

Chief Operating Officer

Reynolds M. Delgado III

Founder & Chief Medical Officer

William Clifton MD

Director, Research and Development

Eric Fain

President and CEO

United States Late Stage Companies With Less Than $10M in Revenue

Greater Houston Area Companies With Fewer Than 1000 Employees (Top 10K)

United States Late Stage Companies With Less Than $500M in Revenue

United States Late Stage Companies With More Than 10 Employees

Procyrion develops technology solutions and offers a catheter-based circulatory support technologies. One in five adults over the age of 40 will develop heart failure in his or her lifetime. For the sickest patients, only 1% receive treatment annually due to scarcity, cost, and high risk of current solutions.

Procyrion, has developed a solution: Aortix is a circulatory support pump implanted without surgery. Thinner than a #2 pencil, a cardiologist can implant Aortix through a catheter in the leg, deploying it between the heart and the kidneys to unload the failing heart and perfuse vital organs. This first-in-class device allows the heart to rest and heal while correcting the fluid imbalance.

The company was founded in 2005 and is based in Houston, Texas.

Series E - Procyrion

Debt Financing - Procyrion

Bluebird Ventures

Series D - Procyrion

Series C - Procyrion

Series B - Procyrion

Venture Round - Procyrion

Series A - Procyrion

Houston

Texas

United States

North America

Procyrion

Medical device co. Procyrion closes $57M Series E round as clinical testing ramps up

Procyrion Closes $57.7M in Series E Funding

Procyrion Closes $57.7 Million in Series E Financing

Procyrion raises $57M to complete development of its percutaneous heart failure pump

Procyrion raises $57.7M Series E for circulatory support device

Procyrion enrolls first patient in mechanical circulatory support ...

Fast Five: J&J makes a $400M acquisition to enter LAA device ...

France

Europe

HTML5

Google Maps API

Google Analytics

Apache Server

Google Tag Manager

Adobe Fonts

jQuery

Office 365

Modernizr

Google Fonts

Developer of implantable technology for hypertension and heart failure

CVRx

Developer of medical devices for heart failure

Sequena Medical

Procyrion, Inc. is a medical device company focused on developing the world's first catheter-deployed heart pump, known as the Aortix system. This innovative technology is designed to assist heart function and improve clinical outcomes for patients with heart failure.

news impact assignment basic	general	May 8, 2024 9:03 AM	a46ff4c0
public peers	general	May 8, 2024 9:03 AM	11fc1b76
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	May 8, 2024 9:03 AM	224d68a4
company summary	general
signals	general
crunchbase trigger	general	Oct 28, 2024 1:51 PM	7fa80503
crunchbase profile	general	Oct 29, 2024 7:57 AM	bc69255a
li profile	general	May 8, 2024 9:03 AM	46db95d6
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	252cebb6
peers	general
news basic	general	May 8, 2024 9:03 AM	7f46345f
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:PROCYRION

Procyrion